$0.7135
-0.0014[-0.20%]
At close: Apr 17
$0.7135
0[0.00%]
PreMarket: 5:13PM EDT
Atara Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Atara Biotherapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/06/2024 | PM | ATRA | Q1 | -$0.72 | -$0.23 | — | — | $1.23M | $27.92M | — | — | Get Alert |
03/28/2024 | AM | ATRA | Q4 | -$0.72 | -$0.48 | -$0.56 | -16.67% | $221.00K | $11.55M | $4.25M | -63.19% | Get Alert |
11/01/2023 | AM | ATRA | Q3 | -$0.82 | -$0.66 | -$0.66 | 0.00% | $4.46M | $4.76M | $2.14M | -55.08% | Get Alert |
08/08/2023 | PM | ATRA | Q2 | -$0.31 | -$0.67 | -$0.68 | -1.49% | $51.58M | $3.77M | $957.00K | -74.62% | Get Alert |
05/08/2023 | PM | ATRA | Q1 | -$0.87 | -$0.39 | -$0.72 | -84.62% | $7.31M | $30.68M | $1.23M | -96.00% | Get Alert |
02/08/2023 | PM | ATRA | Q4 | -$0.96 | -$0.51 | -$0.72 | -41.18% | $7.55M | $39.67M | $221.00K | -99.44% | Get Alert |
11/08/2022 | PM | ATRA | Q3 | -$0.90 | -$0.78 | -$0.82 | -5.13% | $5.37M | $5.27M | $4.46M | -15.39% | Get Alert |
08/08/2022 | PM | ATRA | Q2 | -$0.91 | -$0.93 | -$0.31 | 66.67% | $3.87M | $6.84M | $51.58M | 654.08% | Get Alert |
05/05/2022 | PM | ATRA | Q1 | -$0.86 | -$0.98 | -$0.87 | 11.22% | $3.55M | $4.91M | $7.31M | 48.96% | Get Alert |
02/28/2022 | PM | ATRA | Q4 | -$0.95 | -$0.69 | -$0.96 | -39.13% | $0.00 | $35.14M | $7.55M | -78.52% | Get Alert |
11/04/2021 | AM | ATRA | Q3 | -$0.92 | -$0.94 | -$0.90 | 4.26% | $0.00 | $3.92M | $5.37M | 36.99% | Get Alert |
08/09/2021 | PM | ATRA | Q2 | -$1.14 | -$0.89 | -$0.91 | -2.25% | $0.00 | $3.84M | $3.87M | 0.78% | Get Alert |
05/04/2021 | PM | ATRA | Q1 | -$1.20 | -$0.92 | -$0.86 | 6.52% | $0.00 | $1.60M | $3.55M | 122.00% | Get Alert |
03/01/2021 | PM | ATRA | Q4 | -$1.36 | -$0.74 | -$0.95 | -28.38% | $0.00 | $13.33M | $0.00 | -100.00% | Get Alert |
11/09/2020 | PM | ATRA | Q3 | -$1.31 | -$1.09 | -$0.92 | 15.60% | $0.00 | — | $0.00 | — | Get Alert |
08/05/2020 | PM | ATRA | Q2 | -$1.60 | -$1.18 | -$1.14 | 3.39% | $0.00 | — | $0.00 | — | Get Alert |
05/06/2020 | PM | ATRA | Q1 | -$1.44 | -$1.41 | -$1.20 | 14.89% | $0.00 | — | $0.00 | — | Get Alert |
02/27/2020 | AM | ATRA | Q4 | -$1.75 | -$1.34 | -$1.36 | -1.49% | $0.00 | — | $0.00 | — | Get Alert |
11/07/2019 | AM | ATRA | Q3 | -$1.29 | -$1.44 | -$1.31 | 9.03% | $0.00 | — | $0.00 | — | Get Alert |
Atara Biotherapeutics (ATRA) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on March 28, 2024 for Q4.
The Actual EPS was $-0.56, which missed the estimate of $-0.48.
The Actual Revenue was $4.3M, which missed the estimate of $11.6M.
Browse earnings estimates, EPS, and revenue on all stocks.